USPatentGranted

Intermediates in the synthesis of novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives

Granted 15 Dec 1998 · no office action yet

Assignee: Astra Aktiebolag

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Robin Bernad Boar, Duncan Alastair Gray, Alan John Cross, Richard Alfred Green · Examiner: Keith D. MacMillan

Application
456637
filed 2 Jun 1995
Publication
Not published
not published
Patent· this page
US 5,849,921
granted 15 Dec 1998

Life of the patent

2 dated events
⤢ drag to zoomJul 1995Jan 1996Jul 1996Jan 1997Jul 1997Jan 1998Jul 1998Jan 1999Prosecution
Prosecutionhover for detail · click to open

Abstract

Angiotensin-II antagonists of the formula ##STR1## wherein R.sub.1 is, other than hydrogen and, inter alia, halogen, lower alkyl or cycloalkyl; R.sub.2 is, inter alia, optionally substituted benzimidazol-2-yl, 5,6,7,8-tetrahydro-imidazo›1,2-a!pyridin-2-yl, butanesultam-1-yl, imidazol-4-yl, and tetrahydobenzimidazol-2-yl; R.sub.3 is, inter alia, lower alkyl; and, R.sub.4 is an acidic group, such as carboxyl or tetrazolyl. An exemplary compound is: 4\'-›(2-ethyl-4-methyl-6-(5,6,7,8-tetrahydroimidazo›1,2-a!pyridin-2-yl)-ben zimidazol-1-yl)-methyl!-biphenyl-2-carboxylic acid.

Claims

1 · 1 independent · depth 1
1 granted claims

Classifications

27 codes
USPC · US Patent Classification
546/271.4514/374548/235548/225546/274.4548/236548/232548/100546/274.7548/215548/230548/227548/120514/359548/203548/229548/226548/204548/200548/187548/202548/228548/205548/186514/365548/182546/275.1

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency
3.5 y
1,292 days filing → grant
Office actions
0
on the grant's record
Examiner
Keith D. MacMillan
art unit —
Citations: 8 back · 0 forward

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock